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Abstract
The goal of this project was to establish Electrical Stimulation (ES) in combination with
In Vivo Intracerebral Microdialysis (IVMCD) as a methodology to evoke exocytotic-like
dopamine (DA) release. To provide evidence that ES mimics action potential-mediated DA
exocytosis, we hypothesized that ES produces depolarization of the membrane potential that is
dependent upon sodium (Na+) -channels to produce DA release concomitantly with rotational
behavior. To test this, rats received electrode and cannulae implants along the medial forebrain
bundle, which contains the DAergic nigrostriatal pathway, and a microdialysis probe at the
striatum to undergo IVMCD testing. To begin, steady baseline DA levels were assessed followed
by ES, subsequent post ES samples were collected, followed by an infusion of Na+ channel
blocker, lidocaine. Next, a second phase of ES was applied to assess the effects of lidocaine on
ES-evoked DA overflow, and two additional post ES samples followed. The data indicate that
lidocaine decreased both basal and electrically stimulated DA release, and reduced associated
rotational behavior. The current data support the idea that ES activates Na+ channels to induce
exocytotic-like DA release and rotational behavior. These data validate ES in combination with
IVMCD as an effective methodology to study plasticity of exocytotic mechanisms that alter DA
neurotransmission. Specifically, future research that aims to understand how DA
neurotransmission is altered in behavioral disorders, such as neurodegenerative or substance use
disorders, can utilize this innovative combination of ES and IVMCD.
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Introduction
History of Electrical Stimulation
Electrical stimulation (ES) has played an important role in elucidating how electrical
currents are important in the physiological function of neurons as well as the functional
organization of the nervous system. The role of electricity in biological systems was formally
investigated for the first time in the 18th century when Luigi Galvani discovered that muscle
movements could be evoked when applying electrical current to muscle tissue of the Peripheral
Nervous System (Piccolino, 1997). This discovery helped to conceptualize that a cell has the
capability to generate its own electrical energy. It was not until the late 19th century when
Fritsch and Hitzig revealed that the Central Nervous System was electrically excitable. Using
ES, they discovered that the cortex was important for producing behavior, and that different
behaviors were localized in different locations of the cortex (Fritsch & Hitzig, 1870).
ES has been a valuable tool to map other brain functions beyond the initial findings by
Fritsch and Hitzig. For example, a topographical representation of the cortex was developed
based on electrically evoked sensory and motor behavior (Penfield & Jasper, 1955; Woolsey,
1979). ES of the lateral hypothalamus has also been shown to evoke motivated feeding behavior
(Hoebel & Teitelbaum, 1962; Berridge & Valenstein, 1991) and to discover that other limbic
structures, such as the septal nucleus, modulate reinforcement (Olds & Milner, 1954). Therefore,
ES of brain circuits has been an important tool in neuroscience to elucidate the behavioral
organization of the Central Nervous System.
Thus, ES has been used to explore functional circuits by correlating evoked behaviors
with stimulated brain sites. Moreover, the ability to study the effects of ES at the neuronal level
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has also been a valuable tool in the history of neuroscience. In 1952 the action potential was
characterized using ES to demonstrate how ion permeability changes with depolarization of the
membrane potential (Hodgkin & Huxley 1952). Another in vitro study utilized ES to provide
evidence that inward calcium (Ca++) current is needed for synaptic signaling upon depolarization
(Llinas et al., 1981). Due to the parallels between ES and endogenous mechanisms of release,
this tool has been utilized in vitro to study neurotransmission. For example, ES has been used to
show that the availability of precursor tyrosine can change the magnitude of dopamine (DA)
release (Milner & Wurtman, 1984). ES is now a traditional tool in neuroscience and is
commonly used in vitro and in vivo to study neural mechanisms and behavior (Reynolds &
Wickens, 2000).
Neurotransmission
All behavior is dependent upon neurotransmission, or neuronal communication, that is
comprised of electrophysiological activity that results in neurotransmitter release. One critical
electrophysiological signal is the action potential: This occurs when the resting membrane
potential depolarizes to a critical threshold and voltage-gated sodium (Na+) channels open. This
event triggers a change in the permeability of the membrane allowing extracellular Na+ to rush
into the neuron. This movement of positively charged Na+ ions peaks and Na+ channels become
refractory. The depolarizing changes in the membrane potential subsequently actives voltagegated potassium (K+) channels to open. Electrostatic pressure causes K+ ions to rush out,
resulting in hyperpolarization back towards the resting membrane potential. To terminate the
action potential, there is a refractory period during which a subsequent action potential cannot be
generated. During this time, the resting membrane potential is re-established by extracellular K+
diffusion away from the local site and a Na+/K+ pump. The action potential propagates towards
2

the presynaptic terminal and in response to the depolarizing effects of the action potential,
voltage-dependent Ca++ channels open, allowing Ca++ ions to flux inward. Intracellular Ca++
causes vesicles to dock onto the presynaptic membrane (Söllner et al., 1993). Exocytosis
culminates with neurotransmitter released from the vesicles into the synaptic cleft, the hallmark
of neurotransmission.
A technique that is meant to mimic exocytosis should demonstrate, in part, the three
critical characteristics of action potential-mediated neurotransmitter release: 1) Na+ channeldriven depolarization of the membrane potential, 2) opening of voltage dependent Ca++ channels
allowing the influx of Ca++ into the terminal bouton, 3) and vesicular based release of the
neurotransmitter into the synapse. Therefore, demonstration that a technique, such as ES,
produces exocytotic-like release increases the interpretability of experimental data reflecting
changes in neurotransmission. This thesis begins with a brief review of techniques used to study
DA neurotransmission.
Amphetamine Evoked DA Overflow
Amphetamine has often been used to measure the functional status of DA systems, either
to evoke behavior (Essman et al., 1992) or as a functional index of DA “releasability” (Robinson
et al., 1994). However, amphetamine does not work by exocytotic mechanisms but instead
produces increases in extracellular DA by an exchange/diffusion process (Fischer & Cho, 1979;
Parker & Cubeddu, 1986; Levi & Raiteri, 1993; Raiteri et al., 1979). In exchange for
amphetamine entry, the DA transporter transfers DA from the inner cytoplasmic pool out to the
extracellular environment. Therefore, despite its ability to increase extracellular DA,
amphetamine is not a desirable tool to understand changes in mechanisms of exocytosis.
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Potassium K+ Evoked DA Overflow
K+ stimulation works by depolarizing the membrane, and triggering action potentials that
induce DA release (Stanford et al., 2000). K+ stimulation has been used to investigate changes in
exocytosis following neurotransmitter-depleting lesions (Abercrombie & Zigmond, 1989;
Lindefors et al., 1989). These studies have provided important insights about changes in
depolarization-based release. Nonetheless, a limitation of K+ stimulation by reverse dialysis is
that minimal behavior is displayed upon stimulation (Casanova et al., 2013; Tran-Nguyen et al.,
1996) and the pharmacokinetics of K+ cannot be precisely controlled to mimic the sub-second
timeframe of action potentials. Thus, a better approach is required that addresses the weaknesses
presented by amphetamine and depolarizing stimulation using K+.
Optogenetic Evoked DA Overflow
Optical stimulation works by activating transgenic light-sensitive receptors such as
channelrhodopsin to trigger neurotransmitter release (Deisseroth, 2011). Optogenetics can target
specific neurotransmitter systems. For example, anatomically precise targeting of DA cell bodies
of the substantia nigra increases confidence for DA-specific effects (Bass et al., 2010), which is
not possible with amphetamine, K+ stimulation, or ES. In vitro and in vivo studies have validated
optically induced release as comparable to exocytosis, especially because these light sensitive
receptors can be programmed to express cation channels that naturally trigger depolarization via
transgenic Na+ channels or vesicular docking via transgenic Ca++ channels (Izquierdo-Serra et al.,
2013). Although this technique is more powerful than ES due to specificity, it poses challenges
in studying endogenous receptors. Because optical stimulation exclusively activates light
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sensitive receptors, this poses challenges in studying changes in endogenous receptors that
modulate neurotransmission.
ES-Evoked DA Overflow
ES is a powerful tool to investigate changes in neurotransmission for four reasons: 1) ES
evokes behavior largely related to the function of the locus being stimulated. Specifically,
unilateral ES of the nigrostriatal pathway produces motor behavior in the form of rotational
behavior (Pycock, 1980). 2) Behavioral and neurophysiological responses to ES are intensitydependent (Castañeda et al., 1985) and frequency-dependent (Castañeda, unpublished data). 3)
ES can be precisely turned on and off; thus avoiding the long-enduring pharmacokinetics of drug
stimulation. 4) Lastly, ES activates exocytotic events to produce neurotransmitter release in vitro
(Mulder 1983). These features are important criteria necessary to gain confidence that ES
produces a physiologically relevant response when evoking DA release. However validation that
electrically induced DA release mimics exocytosis in awake and freely moving animals is yet to
be established.
In Vivo Intracerebral Microdialysis (IVMCD) of DA Overflow
Coupled with ES, IVMCD is a powerful choice to study changes in neurotransmission for
four reasons: 1) this technique allows for the sampling of extracellular DA levels while leaving
the brain functionally intact and without disrupting feedback mechanisms from other brain
structures. For example, release can be augmented or attenuated by an intact network circuitry in
a whole animal preparation, in contrast to isolated brain fragments typical of in vitro procedures.
Therefore, IVMCD allows for a more physiologically relevant assessment of neuronal function.
2) IVMCD yields DA samples that can be accurately quantified using biochemical techniques

5

such as high pressure liquid chromatography coupled with electrochemical detection. 3)
Repeated sampling from an animal can continue across extended time periods to gain insight into
the dynamics of DA exocytosis. 4) Lastly, this technique is most powerful for its ability to
estimate the dynamics of exocytosis simultaneously with ongoing behavior in an awake animal
preparation.
ES in Combination with IVMCD
The aim of this thesis is to validate ES in combination with IVMCD as a method to study
exocytotic-like neurotransmitter release concomitantly with an evoked behavioral correlate.
Validation requires the demonstration that modulatory mechanisms of exocytosis are necessary
to evoke the neurochemical and behavioral responses produced by ES. These include: intensityand frequency-dependent responses to ES, Na+ channel-dependent activation, dependence upon
Ca++ availability, Ca++ channel sensitivity, as well as other criteria such as vesicular based
release of the neurotransmitter.
Preliminary unpublished evidence in the laboratory of Dr. Castañeda has already shown
that ES produces intensity-, frequency-, and Ca++ -dependent responses akin to exocytosis. For
example, these data show that the Ca++ channel blocker verapamil attenuates ES-evoked DA
overflow. Also, the Ca++ chelater ethyleneglycol-bis 2 amino-ethylether-N,N,N,N-tetra acetic
acid (EGTA) attenuates ES-evoked DA overflow. The present thesis builds upon this evidence
with converging data that ES, in vivo, is dependent upon Na+ channel driven depolarization.
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Global Hypothesis
The global hypothesis is that ES activates Na+ channel dependent depolarization akin to
action potentials that subsequently produces DA exocytosis. Our working hypothesis is that Na+
channel blockade attenuates electrically induced DA overflow and rotational behavior.
Specific Aims
Specific Aim 1. To determine whether electrically stimulated DA overflow is Na+ channel
dependent
Specific Aim 2. To determine whether electrically stimulated rotational behavior (ESRB) is Na+
channel dependent
To accomplish these specific aims, the Na+ channel blocker lidocaine was infused into the
medial forebrain bundle (MFB) of the nigrostriatal pathway and electrically evoked striatal DA
overflow, measured by IVMCD, and ESRB were quantified. It was predicted that blocking Na+
channels during ES would attenuate DA overflow and ESRB. Figure 1. outlines the
experimental procedures used to address specific aims 1 and 2.

First
Surgery
Electrode &
Cannulae
Implant

Recovery
5 Days

ESRB
5 Days

Second
Surgery
Probe
Implant

Figure 1. Experimental Procedures
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IVMCD
Testing
1 Day

Histology

Methods
Subjects
Male and female Wistar rats weighing 200-500 gm were maintained in 36 X 39 X 19 cm
plastic housing at the vivarium in The University of Texas at El Paso (UTEP) Psychology
department at (Tecniplast) under a reversed 12:12 light/dark cycle (lights off at the 0830). The
UTEP Animal Care Program provided husbandry. Food and water were made available ad lib
during the entire course of the study except during testing. Immediately before experimentation,
all rats were habituated in the testing room by daily handling for 5 days (5-10 min). The UTEP
Institutional Animal Care and Use Committee approved the methodology described herein. Nine
animals completed the following methodological stages of the experiment. Additional animals
were excluded from this study for the following reasons: surgical complications, failure to meet
ESRB criterion, probe failure, and unsecure implants.
First Surgery
Using standard stereotaxic procedures with coordinates by Paxinos & Watson (2006),
with bregma and lambda horizontal to each other, bilateral holes were drilled through the
exposed skull at +0.5 mm anterior to bregma and ±2.5 mm lateral aimed at the caudate nucleus
for future implantation of a microdialysis probe in the second surgery (described below). Next,
bipolar twisted wire stainless steel electrodes (Plastics One MS303/3, 0.150 mm diameter) were
implanted bilaterally aimed at the MFB (coordinates in mm from bregma: A -4.4, L ±1.2, V 8.7).
Stainless steel guide cannulae (23 ga) were also implanted bilaterally aimed at the MFB, at the
level of the lateral hypothalamus (coordinates from bregma in mm A–2.5, L ±1.8, V -5.0). Later,
during IVMCD testing, an infusion cannula was inserted through this guide cannula to the depth
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of the MFB at V 8.4 mm (see IVMCD testing). All implants were secured to the skull with
jeweler's screws tightened into trephines and dental cement. Finally, the scalp was sutured and
dabbed with antibiotic cream.
A Priori Criterion: ESRB
Five days after stereotaxic surgery animals were tested for ESRB before proceeding to
IVMCD testing. For five consecutive days, ES was administered in increasing intensities (50-300
µA in 50 µA intervals) to determine intensity dependence of ESRB. To be included in the
experiment, animals had to satisfy an a priori criterion of at least 8 quarter turns/10 sec at 300
µA. However, 2 of the 9 animals were stimulated at 200 µA to prevent tumbling associated with
higher intensities. ES was delivered by a Grass S9 Stimulator in series with a Grass Constant
Current Unit. ES consisted of monophasic rectangular pulses at 50 Hz, 0.1 ms pulse duration, 10sec train duration, and a 2-min inter-train interval. Each electrode implant was tested using
normal and reversed current flow to determine optimal testing conditions. Essentially, this a
priori testing provided behavioral validation of precise electrode placement into the MFB.
Microdialysis Probe Construction
Microdialysis probes were of concentric design with a 4 mm length effective area of
dialysis (Robinson & Whishaw, 1988). To construct these, cellulose (dialysis membrane) was cut
to a length of 10 mm, and inserted into the edge of a 26 ga 13 mm-length stainless steel cannula,
which was previously acid etched. The dialysis membrane was then glued onto the stainless steel
cannula with 2 ton epoxy (Devcon) and left to dry for a few hours. Next the dialysis membrane
was cut to a length of 4.25 mm; then 0.25 mm of the tip was sealed with 2 ton epoxy and left to
dry overnight. The next day, the outlet PE-20 tubing was pierced 8 mm from one end with a 30
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ga needle and the silica inlet tubing threaded through this piercing. The outlet tubing pressure fits
over the stainless steel cannula and is pushed over the cannula to a length of 5 mm, leaving a 3
mm space between the end of the stainless steel cannula and the entry-point of the silica tubing.
The silica inlet tubing was then pushed through the lumen of the stainless steel cannula and
through the lumen of the dialysis membrane until a 0.25 mm gap was reached between the end of
the silica tubing and the epoxy plug. Finally, the junction between the outlet tubing and the
stainless steel cannula, including the section where the inlet tubing pierces to enter into the probe
assembly, was placed inside a pipette tip, and subsequently filled with 2 ton epoxy.
Efficacy of Microdialysis Probe In Vitro Recovery
In vitro testing was conducted to determine the efficacy of microdialysis probes to collect
DA and its major metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid
(HVA), and the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA). An artificial
cerebrospinal fluid (aCSF, modified Ringer’s buffer medium) containing 128.3 mM Na+, 2.68
mM K+, 1.35 mM Ca++, 2.0 mM Mg++, and 2.0 mM PO4+ was used as dialyzing media at 37o C.
At least one day before in vitro recovery, all test probes were flushed thoroughly. The
flushing procedure consisted of pumping HPLC water through dialysis probes placed in a
solution of 70% ethanol for 30 minutes at a rate of 5.0 µl/min. The ethanol was then replaced
with HPLC grade water and the flow rate was changed to 0.15 µl/min and left to pump
overnight. The next day microdialysis probes were filled with aCSF. At this point, the
microinfusion pump was set to 1.5 µl/min and maintained at this rate throughout the recovery
procedure; the same rate that was used during in vivo testing. After 15 min, the probes were
immersed into aCSF containing 500 pg/µl of DA and 200 pg/µl for each of DOPAC, HVA, and
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5-HIAA (“sampling standard”) for the purpose of calculating a recovery coefficient. The probes
were then allowed to equilibrate to test conditions for 20 min. Next, two 10 min samples were
collected. For quantitation, a 25% dilution of the sampling standard was prepared for analysis of
the in vitro recovery samples; this is within the range of recovery for microdialysis probes with a
4 mm cellulose dialyzing membrane. High performance liquid chromatography coupled with
electrochemical detection (HPLC/EC) was used to measure monoamines (see below). Peak
heights from the standard and samples were used to calculate the percent recovery of probes. In
vitro recovery estimates were used to correct for probe efficiency during in vivo procedures,
although it is acknowledged that in vitro conditions do not mimic the “tortuosity” of the in vivo
milieu (Benveniste et al., 1989).
Second Surgery - Microdialysis Probe Implantation
Rats that met the a priori criterion for reliable ESRB underwent a second stereotaxic
surgery to implant a microdialysis probe into the caudate nucleus (flat skull, from bregma A
+0.5, L ± 2.5, V -7.0) ipsilateral to the effective electrode. The stereotaxic surgery proceeded as
described for electrode implantation except that a microdialysis probe was lowered into the
caudate nucleus region, where DA is released. When this surgery was complete, rats had fluid
lines, for perfusing the microdialysis probe, and electrical wiring, connected to the stimulating
electrode, emanating from a dental acrylic pedestal and were placed into a testing chamber (30 X
35 cm) to recover from the surgery overnight. Microdialysis testing took place the next day.
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IVMCD

Minutes:

20 20

20

Baselines

10

10

10

ES

Post ES

10

10 10 10

Lidocaine

ES

10

10

20

Post ES

A

Figure 2. IVMCD Timeline

Experiment (Aim 1 & Aim 2)
Figure 2 outlines the test conditions and timeline for IVMCD. To begin, 20-min samples
were collected to establish baseline levels of DA overflow. Baseline samples were collected until
3 samples varied <10% from each, usually 3-5 sample collections.
Next, unilateral ES (monophasic rectangular pulses, 0.1 msec pulse duration, 50 Hz) was
applied for 10 sec every 2 min during a 10-min sampling bin. The current applied was 300 µA,
the highest intensity used during a priori procedures. ESRB was recorded during ES only.
Post ES, two 10-min samples were collected to reestablish baseline.
Next all animals received lidocaine treatment (4% lidocaine at 0.5 µl/min infusion rate
over 12 min). The microinfusion took place via a 30 ga microinfusion cannula inserted 8.4 mm
below skull surface through the previously implanted guide cannula, thus targeting the MFB.
Three 10-min samples were collected thereafter to establish a steady-state baseline under
lidocaine conditions.
ES was applied as during the previous control conditions and ESRB was counted.
Subsequently, two 10-min post ES samples were collected.
To serve as a positive control, 1.5 mg/kg/ml of amphetamine (A) was administered
intraperitoneally to verify the animal preparation was viable. One 20-min sample was collected
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immediately thereafter. Dialysate samples were quantified using HPLC/EC based on standards
injected into the system.
HPLC/EC Methodology
HPLC/EC methodology consists of two phases for analysis - separation and detection,
which are used to assay for brain DA, its major metabolites DOPAC and HVA, and the serotonin
metabolite 5-HIAA.
Reverse Phase Chromatography
Standards and dialysate samples were injected onto an HPLC system via a Rheodyne
Model 7125 manual injector. The system consisted of an ESA Model 584 dual piston pump set at
a rate of 0.5 ml/min in continuity with a pulse dampener. The stationary phase of the HPLC was
a 15 cm length Dynamax reverse-phase column (C-18; 8 µm particles, 0.46 cm i.d.; Varian Inc).
The mobile-phase consisted of 60 mM sodium phosphate, 30 mM citric acid, 0.1 mM EDTA,
20mg/liter sodium dodecyl sulfate and 20% methanol at a pH of 3.75. The order of elution was
DOPAC, 5-HIAA, HVA, and DA and the run time of approximately 10 min.
Electrochemical Detection
To decrease background noise, the samples were passed through a conditioning cell (ESA
Model 5021) set to oxidize at +100mV. Next, a High Sensitivity Analytical Cell (ESA Model
5010) was used with the first electrode set to oxidize at +340 mV (500 nA sensitivity) and the
second electrode was set to reduce at -340 mV (5 nA sensitivity). A Coulochem II detector
(Model 5200A) was used to measure the amount of analytes based on the peak height generated.
The chromatographs were obtained by EZChrom SI software (Agilent Technologies).
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Histology
Animals underwent post mortem intracardiac perfusion. First, buffered saline was
perfused to remove blood followed by 4% formaldehyde in buffered saline to fixate the brain.
The brain was then removed from the skull and placed into 30% sucrose paraformaldehyde.
Once the brain was submerged, the solution was replaced until the brain sunk again. The brain
was then sectioned in a coronal plane on a Leica CM 1850 cryostat. Brain slices were stained
with cresyl violet and examined for placement of electrodes, infusion cannulae, and
microdialysis probes.
Criteria for accurate placement of probes included those that were within the corpus of
the striatum. Criteria for accurate placement of infusion cannulae included those that extended at
least 2 mm above the MFB for a sufficient sphere of lidocaine diffusion. All animals that met the
a priori behavioral criterion for ESRB for 8 turns/10 sec train were included and examined for
electrode placement at the MFB.
Statistical Analysis
Statistics were conducted using Prism™ (GraphPad software v6). For DA, DOPAC,
HVA and 5HIAA one way repeated measures ANOVAs were conducted across the three time
bins sampled during baselines before and after lidocaine infusion; then two-way repeated
measures ANOVAs were conducted to examine the effects of ES and lidocaine. When a main
effect for repeated measures was found, a follow up one-way repeated measures ANOVA was
conducted for each phase of lidocaine treatment (before, after). The Geisser-Greenhouse
correction was used when sphericity was violated (i.e., epsilon < 1.0). When significant main
effects were found, post-hoc Sidak and Tukey tests were used for pair-wise comparisons. For
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ESRB, a two-way repeated measures ANOVA was used to evaluate the effects of lidocaine
during the five trains of ES.
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Results
Effect of Lidocaine on Electrically

A.

❊!!
❊!!
❊!!

DA (fmol/min)
(fmol/min)
DA
DA fmol/min

Stimulated DA Overflow (Figure 3A):

40
40
40

A one-way repeated measures

Before
Lidocaine
Before
Lidocaine
Before
Lidocaine
After
Lidocaine
After
Lidocaine
After
Lidocaine

DA
DA
DA

❊!!
❊!!
30
30
30 ❊!!

ANOVA was conducted for the 3 baseline

20
20
20

samples collected before ES (data not

10
10
10

shown). There was no change across time

ESESES
BB

B.

before lidocaine (F1.59, 12.72 = 0.30, p >0.05)

B
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1

22
2

3 3
3

ESRB
ESRB
ESRB

30
30
30

1/4 Turns)
Turns
(1/4
1/4 Turns

or after lidocaine (F1.33, 10.61 = 0.08, p >0.05).

20
20
20

Therefore, the average of these baseline
intervals was used in subsequent analyses.

❊!!
❊!!
❊!!

10
10
10

Figure 3A illustrates DA levels

10
sec
Time
Bins
10
sec
Time
Bins
10
sec
Time
Bins
(2(2min
ISI)
min
ISI)
(2 min ISI)

within the time course of ES before
lidocaine and after lidocaine microinfusion.
A 2-way (lidocaine, time) repeated measures
ANOVA was conducted. A significant effect
of lidocaine treatment was found (F1, 8 =
17.56, p<0.05), indicating that in general
lidocaine decreased DA levels. During
baseline, a post-hoc test revealed a
significant decrease in DA levels in response
to lidocaine treatment compared to control
conditions (Sidak, p<0.05). During ES, there

Figure 3. Effect of Lidocaine on A) Electrically Evoked DA, and B)
ESRB
A) Extracellular levels of DA (fmol/min) were measured during
baseline (B), a 10-min collection interval (1) during which ES (❙)
was applied (5 X 10-sec trains, 2-min ISI), and two additional 10min intervals (2,3).	
  Animals were tested under control conditions
(before lidocaine infusion, ) and following lidocaine treatment
(¡). After lidocaine infusion, there was a decrease in baseline (B)
DA levels compared to control conditions (❊, p< 0.05). Extracellular
levels of DA during ES were also significantly reduced by lidocaine
compared to control conditions (❊, p< 0.05). ES increased
extracellular levels of DA during control conditions (, p< 0.05).
Immediately after ES, DA levels returned to baseline levels
(p’s>0.05). In the lidocaine condition, there were no significant
differences across time.
B) ESRB was measured in quarter turns during the 10-min interval
in which ES was applied in five 10-sec trains (2-min ISI). Prior to
lidocaine () all animals demonstrated vigorous contraversive
turning in response to ES. After lidocaine (¡) there was a significant
reduction in turning compared to turning during control conditions
(❊, p< 0.05). In both conditions, the rate of turning was sustained
across the 5 trains of ES (p>0.05).
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was also a significant decrease in extracellular DA levels under lidocaine treatment compared to
control conditions (Sidak, p<0.05).
A significant main effect of repeated measures across time was found (F3, 24 = 12.40, p<
0.05). A follow-up 1-way repeated measures ANOVA conducted during the control phase
(before lidocaine treatment) revealed a significant change in DA across time (F2.07, 16.57 = 11.50,
p< 0.05). Post-hoc pairwise comparisons revealed a significant increase in extracellular DA
levels during ES compared to all other timepoints (Tukey, p’s<0.05). A 1-way repeated measures
ANOVA for the lidocaine phase was not significant (F1.54, 12.32 = 3.01, p>0.05). A significant
interaction (lidocaine X time) was found (F3, 24 = 3.90, p< 0.05) indicating that extracellular DA
levels between control versus lidocaine treatment varied as a function of time.
Effect of Lidocaine on ESRB (Figure 3B):
Figure 3B illustrates ESRB before lidocaine and after lidocaine microinfusion. A 2-way
(lidocaine, ES) repeated measures ANOVA was conducted. A significant main effect of
lidocaine treatment was found (F1, 8 = 7.74, p< 0.05) indicating that in general lidocaine
decreased ESRB. During every ES train, post-hoc tests revealed a significant decrease in ESRB
in response to lidocaine treatment compared to control conditions (Sidak, p’s<0.05). There was
no significant main effect for ES (F4, 32 = 0.72, p>0.05), indicating that ESRB remained
consistent throughout the five ES time bins. There was no significant interaction (lidocaine X
ES) found (F4, 32 = 1.16 p>0.05).
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Figure 4A illustrates DOPAC levels
within the time course of ES before
lidocaine and after lidocaine microinfusion.

significant effect of lidocaine treatment was
found (F1, 8 = 9.13, p< 0.05) indicating that
in general lidocaine increased DOPAC

control conditions (Sidak, p<0.05). During
both post ES samples, there was also a
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Figure 4. Effect of Lidocaine on ES-Evoked Metabolite Overflow A) DOPAC, B) HVA, C) 5HIAA
Extracellular levels of monoamine metabolites (fmol/min) were measured during baseline (B), a 10-min collection interval (1) during
which ES (❙) was applied (5 X 10-sec trains, 2-min ISI), and two additional 10-min intervals (2, 3).	
  Animals were tested under control
conditions (before lidocaine infusion, ) and following lidocaine treatment (¡).
A) DOPAC: After lidocaine infusion, there was an increase in DOPAC levels during ES compared to control conditions (❊, p< 0.05).
Under lidocaine condition, extracellular levels of DOPAC during post ES samples (2 & 3) remained significantly increased (❊, p’s<
0.05). ES increased extracellular levels of DOPAC based on the results of the 2-way ANOVA repeated measures factor (p<0.05); but
neither treatment factor alone yielded a significant change across time (p’s=0.07).
B) HVA: After lidocaine infusion, there was an increase in HVA levels during ES compared to control conditions (❊, p< 0.05). Under
lidocaine condition, extracellular levels of HVA during post ES samples (2 & 3) remained significantly increased (❊, p’s< 0.05). In
contrast to ES, HVA levels increased during the last post ES sample (3) (, p<0.05).
C) 5HIAA: After lidocaine infusion, there was an increase in 5-HIAA levels during ES compared to control conditions (❊, p< 0.05).
Under the lidocaine condition, extracellular levels of 5-HIAA during post ES samples (2 & 3) remained significantly increased (❊, p’s<
0.05).
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significant increase in extracellular DOPAC levels under lidocaine treatment compared to
control conditions (Sidak, p’s<0.05).
A significant main effect of repeated measures was found (F3, 24 = 7.05, p< 0.05)
indicating a general increase in DOPAC levels across time. Follow-up 1-way repeated measures
ANOVAs for each treatment condition, before and after lidocaine, revealed no significant
changes in DOPAC levels across time. There was no significant interaction (lidocaine X time)
found (F3, 24 = 1.28, p>0.05).
Effect of Lidocaine on ES-Evoked HVA Overflow (Figure 4B):
Figure 4B illustrates HVA levels within the time course of ES before lidocaine and after
lidocaine microinfusion. A 2-way (lidocaine, time) repeated measures ANOVA was conducted.
A significant effect of lidocaine treatment was found (F1, 8 = 16.04, p <0.05) indicating that in
general lidocaine increased HVA levels. During ES, a post-hoc test revealed a significant
increase in HVA levels in response to lidocaine treatment compared to control conditions (Sidak,
p<0.05). During both post ES samples, there was also a significant increase in extracellular
HVA levels under lidocaine treatment compared to control conditions (Sidak, p’s<0.05).
A significant main effect of repeated measures across time was found (F3, 24 = 8.26, p<
0.05). A follow-up 1-way repeated measures ANOVA conducted during the control phase
(before lidocaine treatment) revealed a significant change in HVA across time (F 2.17, 17.36 = 5.12,
p< 0.05). Post-hoc pairwise comparisons revealed a significant increase in extracellular HVA
levels during the last post ES sample compared to ES (Tukey, p<0.05). A 1-way repeated
measures ANOVA conducted during the treatment phase (after lidocaine treatment) revealed a
significant change in HVA across time (F1.50, 11.97 = 6.15, p< 0.05) although there were no
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significant differences in post-hoc pairwise comparisons. A significant interaction (lidocaine X
time) was found (F3, 24 = 3.61, p< 0.05) indicating that extracellular HVA levels between control
versus lidocaine treatment varied as a function of time.
Effect of Lidocaine on ES-Evoked 5HIAA Overflow (Figure 4C):
Figure 4C illustrates 5HIAA levels within the time course of ES before lidocaine and
after lidocaine microinfusion. A 2-way (lidocaine, time) repeated measures ANOVA was
conducted. A significant effect of lidocaine

ESRB as a Function of DA
DA and ESRB

treatment was found (F1, 8 = 15.01, p<0.05)

Turns
1/41/4
Turns

200
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revealed a significant increase in 5HIAA levels
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Figure 5. Linear regression analysis of ESRB in
relation to ES-Evoked DA Overflow.

post ES samples, there was also a significant
increase in extracellular 5HIAA levels under

Only data prior to lidocaine infusion () were used to
display the relationship between ESRB as a function of
ES-evoked DA. There was no significant correlation
between ES-evoked DA overflow and turning (r=-0.01,
p>0.05).

lidocaine treatment compared to control
conditions (Sidak, p’s<0.05).

There was no significant main effect of repeated measures across time (F3, 24 = 1.36)
p>0.05). However, a significant interaction (lidocaine X time) was found (F3, 24 = 3.39, p< 0.05)
indicating that extracellular 5HIAA levels between control versus lidocaine treatment varied as a
function of time.
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Correlation between Electrically Stimulated Rotational Behavior and DA Overflow (Figure 5):
Figure 5 illustrates ESRB as a function of ES-evoked DA levels. ES-evoked DA levels were
calculated as the difference in the amount of extracellular DA evoked by ES from baseline
levels. These data produced a Pearson correlation coefficient of -0.01, which was not
statistically significant (p>0.05).

B. Infusion Cannula

A. IVMCD Probe

C. Electrode

Bregma
+1.2

-1.8

-3.8

+0.2

-2.3

-4.3

-.26

-2.56

-4.8

-2.8

Histological Verification for
Figure 6. Histological Verification for
Accurate Placement of A) Probe, B) -3.14
Infusion Cannula, C) and Electrode

Accurate Placement of
Implantations (Figure 6):

-3.3

Histology was performed on
eight brains out of the nine

-3.6

animals used in this study.
Accurate placement of probes in the striatum (A), infusion cannulae in the MFB (B), and
electrodes in the MFB (C) were verified in each animal (see methods).

21

A. ESRB

B. ES-EVOKED DA

Turning and DA Intensity

Bregma
-3.8

-4.3

-4.8

Figure 7. Anatomical Location of Electrode and Intensity of ES-Evoked A) Turning, and B)
DA Overflow

Anatomical Location of Electrodes Associated with Intensity of Electrically Evoked Rotational
Behavior and DA Overflow (Figure 7 A,B):
Coronal sections are displayed in an anterior to posterior direction from top to bottom,
respectively. Intensities for both turning (A) and ES-evoked DA overflow (B) are indicated by a
color spectrum where low intensities are associated to yellow and higher intensities are
associated in a continuum to red. A) Intensity of turning is plotted for each animal, as a function
of electrode location. Turning intensities ranged from 20-150 quarter turns within the 10-min ES
time bin. It was casually observed that more medial placements generally evoked greater turning.
B) Intensity of ES-evoked DA is plotted for each animal as a function of electrode location.
Intensities of ES-evoked DA overflow ranged from 2-30 fmol/min during the 10-min ES time
bin. The data do not show a clear relationship between ES-evoked DA overflow with electrode
placement.
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Discussion
Effect of Lidocaine on Electrically Stimulated DA Overflow and Rotational Behavior
The present data support the hypotheses that electrically induced DA release and ESRB
are dependent upon Na+ channels. ES applied at the nigrostriatal axons as they emerge from the
substantia nigra evoked striatal DA overflow and ESRB. These neurochemical and behavioral
responses were attenuated by the Na+ channel blocker lidocaine microinfused downstream from
ES at the MFB as it courses through the lateral hypothalamus. It is well accepted that ES
produces depolarization to activate Na+-dependent action potentials, subsequently producing
exocytosis (Mulder et al., 1983). Therefore, the present data infer that ES in combination with
IVMCD can be used to reliably evoke exocytotic-like DA release. The demonstration of Na+
channel sensitivity complements additional unpublished data showing that ES-evoked DA
overflow and ESRB are intensity- and frequency- dependent, as well as require Ca++ availability.
The premise of this thesis was to demonstrate that ES used in combination with IVMCD
is a methodological approach that evokes exocytotic-like overflow of DA concomitantly with
rotational behavior. Taken together, the present results combined with previously collected
parametric data establish that electrically evoked DA overflow reflects activation of the
physiological mechanisms involved in exocytosis. Specifically, ES mimics the depolarization of
the membrane produced by an action potential, given that the sodium channel blocker attenuated
both the neurochemical and behavioral responses to ES. ES, under the present conditions, evokes
calcium-dependent overflow, given that calcium chelation and L-type calcium channel blockade
reduced both DA overflow and ESRB. Notably, calcium-mediated vesicular docking is a
characteristic of exocytosis. Finally, the evoked DA overflow and rotational behavior are
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stimulus bound, frequency-dependent, and intensity-dependent, indicating that exocytotic
mechanisms are recruited in these responses rather than being due to nonspecific effects (eg,
damage-induced effects).
The significant contribution of the present thesis is that it provides validation for a
methodology that produces a physiologically meaningful estimate of exocytotic events.
Traditional techniques used to stimulate DA overflow have failed to produce physiologically
relevant responses. Although amphetamine is widely used to produce DA overflow, it is not a
desirable tool to understand changes in mechanisms of exocytosis because of its mechanism of
action on the reuptake protein. In contrast, K+ stimulation does increase extracellular DA by
depolarization, but it does not effectively evoke a readily measurable behavioral response.
Therefore, ES is an attractive tool used in combination with IVMCD.
The elegance of ES in combination with IVMCD is the ability to compare simultaneously
evoked behavior with physiologically relevant responses. This study shows concomitantly
evoked DA overflow and rotational behavior upon ES. Furthermore, both responses were
significantly reduced by Na+ channel blockade.Together these data validate the use of ES and
IVMCD as an effective way to investigate presynaptic modulators of DA neurotransmission
directly with changes in rotational behavior. It is important to note that the rate of ESRB was
sustained across the five repeated trains of ES. These data suggest that DA levels evoked by ES
using the present paradigm did not diminish throughout repeated stimulation, although this needs
to be examined in future studies.
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Effect of Lidocaine on ES-Evoked Metabolite Overflow
ES produced only a non-significant trend towards increases for extracellular DOPAC that
was significantly augmented by lidocaine treatment. Extracellular levels of HVA were only
significantly increased during the second 10-min sample following the last ES in comparison to
the levels measured during ES. Similar to DOPAC, extracellular HVA was significantly
augmented by lidocaine treatment. A similar pattern was observed for 5-HIAA. Therefore, the
relationship between histological targets, DA, and ESRB was assessed, and this is discussed
below (Relationship between ESRB, DA Overflow and Anatomical Location of Electrode).
In contrast to DA overflow, Na+ channel blockade did not reduce the amount of
metabolites after ES. Previous studies show a positive relationship between spontaneous levels
of DA and associated metabolites (Castañeda et al., 1990). Surprisingly, lidocaine produced an
increase in all three metabolites. Immediately following lidocaine infusion, three 10-min
baselines samples were taken to assess the effects of lidocaine prior to ES. All three baselines for
monoamine metabolites remained stable across the three samples. Given that, in the control
condition, there was no significant change in extracellular DOPAC and 5-HIAA levels but there
was an increase in HVA, a number of alternative explanations must be contended. First, it is
possible that there is a delayed effect of lidocaine that manifests well after the 30-min test for the
effects of lidocaine by itself. If this is true, then this study lacked a sufficient assessment of the
effects of lidocaine alone on DA and metabolites without a confound of ES. This is a concern
because another Na+ channel blocker, halothane, is associated with increases in DA metabolism
(Adachi et al., 2005). Second, there could be an interaction effect between lidocaine and ES that
was observed in the enhancement of all three metabolites during and after ES in comparison to
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control conditions. Further research will be needed to address this issue to elucidate the
mechanism of action of lidocaine on changes in metabolism assessed with IVMCD.
Relationship between ESRB, DA Overflow and Anatomical Location of Electrode
An attempt was made to assess whether the anatomical location of electrodes
corresponded to the effectiveness of ES to evoke DA overflow and ESRB. There was a minor
pattern for more medially placed electrodes to evoke greater ESRB, but there was no readily
observable relationship for electrode placement and ES-evoked DA overflow. In addition, there
was no correlation observed between ES-evoked DA overflow and ESRB. These latter
comparisons were actually beyond the scope of the present study, and a lack of any correlation is
likely due to a number of factors: 1) A greater sample size was needed. 2) The intensity of ES
was not allowed to vary randomly to create a true correlation with ESRB; in fact, a ceiling effect
may have existed because of the high intensity of current used. 3) Electrode placements were
narrowly clustered, limiting any variance in DA levels and ESRB as a function of randomized
electrode placement. Properly designed experiments to investigate the relationship between
anatomical placement of electrodes, ES-evoked DA overflow and ESRB are needed. A more
succinct understanding of these relationships may improve the interpretation of hypothesisdriven research utilizing ES with IVMCD.
Future use of ES in Combination with IVMCD
ES in combination with IVMCD will be a valuable tool for behavioral neuroscience
research of plasticity in DA systems. It is likely that common mechanisms are shared across
development of the Central Nervous System, learning and memory, recovery of function, and
drug addiction. Utilizing the concept of “turnover” that describes the life cycle of DA (Cooper et
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al., 2003, p.230-231) based on a stream of factors (ie, synthesis, vesicular storage, exocytosis,
receptor activation, reuptake, enzymatic degradation) provides a framework of presynaptic
targets that modulate plasticity of neurotransmission. For example, this technique will be used to
investigate such presynaptic mechanisms of neural plasticity that augment DA release in a
denervated state, modeling Parkinson’s disease, where surviving neurons have been previously
shown to normalize extracellular DA levels (Stachowiak et al., 1987; Castañeda et al., 1990) and
the compensatory mechanisms remain unknown. In addition, repeated stimulant drug exposure
in a model of substance abuse disorder leads to an enhancement of DA release in the presence of
drug-paired stimuli (Duvauchelle et al., 2000). Unfortunately, the presynaptic mechanisms that
modulate conditioned DA release are largely unexplored. Until this is solved, measures of DA
release will remain phenomenological. This innovative combination of ES with IVMCD will
help to find key targets that may accelerate the development of therapies in DA-associated
disorders.
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